Skip to main content

815MNB to Showcase Neuraon Assist Wellness Headband at CES 2027

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

- Real-time heart rate and HRV monitoring automatically adjusts noninvasive vagus nerve stimulation (VNS)

- Hands-free relaxation and pre-sleep unwinding without complex data charts or manual app controls

- Expanding R&D from consumer wellness into clinical therapeutics targeting a 2028 commercial launch

815MNB, a South Korean wearable health-tech company (CEO Yongwon Choi), announced today that it will showcase its flagship wellness headband, Neuraon Assist, at CES 2027 in Las Vegas. Designed for modern individuals who struggle to unwind during hectic days or find themselves physically exhausted yet wide awake at bedtime, the device offers an effortless approach to daily stress relief and sleep preparation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119851148/en/

815MNB’s Neuraon Assist wellness headband (Image: 815MNB)

815MNB’s Neuraon Assist wellness headband (Image: 815MNB)

William Marcel Sauve, Chief Technology Officer (CTO) at 815MNB, said, "Conventional wearable devices and stress scores can show people how their day has affected them, yet they still leave users to figure out what to do next." He added, "Neuraon Assist was born out of that familiar frustration. Instead of adding another layer of data to analyze, it eases that burden by automatically adjusting stimulation while the wearer simply takes a break."

At the core of Neuraon Assist is a proprietary closed-loop biofeedback system. The lightweight headband continuously tracks the user’s heart rate and heart rate variability (HRV), compares the readings against their personal baseline patterns, and delivers gentle, personalized noninvasive vagus nerve stimulation (VNS). It then measures the wearer’s real-time physiological response to dynamically guide the next adjustment. This automated process allows users to rest deeply without having to interpret complicated charts, interact with smartphone apps, or manually change settings throughout a session.

Alongside its growing consumer wellness business, 815MNB is actively expanding its research and development pipeline into specialized therapeutic applications. Current research initiatives explore potential interventions for developmental disabilities, cognitive health in older adults, post-traumatic stress disorder (PTSD), and behavioral or substance addictions involving gambling, drugs, or alcohol. The company expects to begin launching commercial products stemming from this clinical research in 2028.

About 815MNB

815MNB is a South Korean wearable technology innovator dedicated to developing closed-loop, bio-signal-based wellness and therapeutic solutions. By bridging real-time physiological monitoring with noninvasive neuromodulation, 815MNB aims to improve daily relaxation, restorative sleep, and long-term cognitive well-being. For more information, please visit www.815mnb.com.

Neuraon Assist was born out of that familiar frustration. Instead of adding another layer of data to analyze, it eases that burden by automatically adjusting stimulation while the wearer simply takes a break.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.82
-10.55 (-4.10%)
AAPL  342.56
-6.65 (-1.90%)
AMD  424.39
-64.80 (-13.25%)
BAC  47.04
-1.53 (-3.15%)
GOOG  264.00
-7.02 (-2.59%)
META  560.84
-35.38 (-5.93%)
MSFT  484.52
-13.78 (-2.77%)
NVDA  125.53
-20.45 (-14.01%)
ORCL  101.19
-9.38 (-8.48%)
TSLA  345.82
-28.59 (-7.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.